aTYR PHARMA INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2019 to Q4 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
aTYR PHARMA INC quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2019 to Q4 2024.
- aTYR PHARMA INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 74.3M shares, a 38.5% increase year-over-year.
- aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 74.3M shares, a 38.5% increase from 2023.
- aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 53.6M shares, a 88.6% increase from 2022.
- aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 28.4M shares, a 48.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)